Walker Neal

CIK 0001604457

President and CEODirector

Filings

Latest Feb 6, 2026

Issuers covered

Showing

34 of 34

Page 1

Track record

15 of 15 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).

Horizon	Trades	Win rate	Avg	Median	Best	Worst
30 days	15	87%	+22.7%	+20.9%	+50.7%	-24.1%
90 days	15	80%	+26.3%	+37.2%	+47.3%	-6.8%
180 days	15	67%	+17.8%	+30.5%	+41.8%	-41.3%
365 days	15	93%	+71.8%	+91.6%	+92.9%	-8.8%

Issuers

Companies where Walker Neal has filed

Ticker	Issuer	Filings	Last filed
ACRS	Aclaris Therapeutics, Inc.	29	Feb 6, 2026
ALDX	Aldeyra Therapeutics, Inc.	5	Jun 12, 2025

All filings

34 Form 4 / 4-A filings, newest first

Filed	Issuer	Top transaction	Shares	Price	Value
Feb 6, 2026	ACRSAclaris Therapeutics, Inc.	Holdings only	-	-	-
Feb 5, 2026	ACRSAclaris Therapeutics, Inc.	FTax	18,611	$3.47	$64,580
Jan 5, 2026	ACRSAclaris Therapeutics, Inc.	FTax	9,952	$2.88	$28,662
Jun 12, 2025	ALDXAldeyra Therapeutics, Inc.	Holdings only	-	-	-
May 5, 2025	ACRSAclaris Therapeutics, Inc.	FTax	2,975	$1.38	$4,106
Apr 3, 2025	ACRSAclaris Therapeutics, Inc.	FTax	3,042	$1.48	$4,502
Mar 4, 2025	ACRSAclaris Therapeutics, Inc.	FTax	3,277	$1.99	$6,521
Feb 4, 2025	ACRSAclaris Therapeutics, Inc.	FTax	3,559	$2.48	$8,826
Jan 3, 2025	ACRSAclaris Therapeutics, Inc.	FTax	13,532	$2.48	$33,559
Dec 6, 2024	ACRSAclaris Therapeutics, Inc.	FTax	68,343	$3.76	$256,970
Dec 3, 2024	ACRSAclaris Therapeutics, Inc.	FTax	2,721	$4.07	$11,074
Nov 5, 2024	ACRSAclaris Therapeutics, Inc.	FTax	2,721	$2.09	$5,687
Oct 3, 2024	ACRSAclaris Therapeutics, Inc.	FTax	2,722	$1.18	$3,212
Sep 4, 2024	ACRSAclaris Therapeutics, Inc.	FTax	2,722	$1.18	$3,212
Aug 13, 2024	ACRSAclaris Therapeutics, Inc.	MExercise	43,548	$0.72	$31,355
Aug 5, 2024	ACRSAclaris Therapeutics, Inc.	FTax	2,722	$1.32	$3,593
Jul 3, 2024	ACRSAclaris Therapeutics, Inc.	FTax	2,722	$1.15	$3,130
Jun 6, 2024	ALDXAldeyra Therapeutics, Inc.	Holdings only	-	-	-
Jun 4, 2024	ACRSAclaris Therapeutics, Inc.	FTax	2,722	$1.03	$2,804
May 3, 2024	ACRSAclaris Therapeutics, Inc.	FTax	2,784	$1.26	$3,508
Apr 3, 2024	ACRSAclaris Therapeutics, Inc.	FTax	3,224	$1.26	$4,062
Mar 5, 2024	ACRSAclaris Therapeutics, Inc.	FTax	3,223	$1.24	$3,997
Feb 5, 2024	ACRSAclaris Therapeutics, Inc.	Holdings only	-	-	-
Aug 24, 2023	ALDXAldeyra Therapeutics, Inc.	MExercise	9,604	$0.552	$5,301
Jul 5, 2023	ALDXAldeyra Therapeutics, Inc.	Holdings only	-	-	-
Mar 3, 2023	ACRSAclaris Therapeutics, Inc.	SSale	30,240	$12.6346	$382,070
Feb 3, 2023	ACRSAclaris Therapeutics, Inc.	SSale	25,000	$16.747	$418,675
Jan 4, 2023	ACRSAclaris Therapeutics, Inc.	SSale	23,382	$15.1855	$355,067
Jun 9, 2022	ALDXAldeyra Therapeutics, Inc.	Holdings only	-	-	-
Apr 25, 2022	ACRSAclaris Therapeutics, Inc.	SSale	25,000	$15.2379	$380,948
Mar 14, 2022	ACRSAclaris Therapeutics, Inc.	SSale	56,303	$15.9147	$896,045
Mar 3, 2022	ACRSAclaris Therapeutics, Inc.	MExercise	96,150	-	-
Feb 11, 2022	ACRSAclaris Therapeutics, Inc.	SSale	3,595	$12.6602	$45,513
Feb 3, 2022	ACRSAclaris Therapeutics, Inc.	MExercise	10,800	-	-

Showing 1-34 of 34

Page 1 of 1

Real-time Form 4 intelligence. Smarter insider tracking.

Filed		Top transaction	Shares	Price	Value